Adiponectin protects against paraquat-induced lung injury by attenuating oxidative/nitrative stress

• Published in: Experimental and therapeutic medicine Vol. 9; no. 1; pp. 131 - 136
• Main Authors: YAO, RONG, ZHOU, YAXIONG, HE, YARONG, JIANG, YAOWEN, LIU, PENG, YE, LEI, ZHENG, ZHIJIE, LAU, WAYNE BOND, CAO, YU, ZENG, ZHI
• Format: Journal Article
• Language: English
• Published: Greece D.A. Spandidos 01.01.2015; Spandidos Publications; Spandidos Publications UK Ltd
• Subjects: Animals; Edema; Experiments; globular adiponectin; Health aspects; Herbicides; Hypotheses; Kinases; Lung diseases; lung injury; nitrative stress; Oxidative stress; paraquat; Physiological aspects; Poisoning; Prevention; Protein hormones; Proteins; Risk factors; Rodents; Toxicity; Toxicology; United States; China; United States > US; nitrative stress; paraquat; lung injury; globular adiponectin; oxidative stress
• ISSN: 1792-0981; 1792-1015
• DOI: 10.3892/etm.2014.2073

The specific mechanisms underlying paraquat (PQ)-induced lung injury remain unknown, which limits understanding of its cytotoxic potential. Although oxidative stress has been established as an important mechanism underlying PQ toxicity, multiple antioxidants have proven ineffective in attenuating the deleterious effects of PQ. Adiponectin, which shows anti-oxidative and antinitrative effects, may have the potential to reduce PQ-mediated injury. The present study determined the protective action of globular domain adiponectin (gAd) on PQ-induced lung injury, and attempted to elucidate the underlying mechanism or mechanisms of action. BALB/c mice were administered PQ, with and without 12 or 36 h of gAd pre-treatment. The pulmonary oxidative/nitrative status was assessed by measuring pulmonary O2*−, superoxide dismutase (SOD), malondialdehyde (MDA), nitric oxide (NO) and 8-hydroxy-2-dydeoxy guanosine (8-OHdG) production, and blood 3-Nitrotyrosine (3-NT). At a dose of 20 mg/kg, PQ markedly increased O2*−, SOD, MDA, NO and 8-OHdG production 3 h post-administration, but did not significantly increase 3-NT levels until 12 h. gAd inhibited these changes in a dose-dependent manner, via transient activation of MDA, followed by attenuation of MDA formation from 6 h onwards. Histological analysis demonstrated that gAd decreased interstitial edema and inflammatory cell infiltration. These results suggest that gAd protects against PQ-induced lung injury by mitigating oxidative/nitrative stress. Furthermore, gAd may be a potential therapeutic agent for PQ-induced lung injury, and further pharmacological studies are therefore warranted.